Clinistique
Board
1 director, no change since 2024Director (not named in the articles)
appointed by deed of 15-12-2017
term without a fixed end
earlier manager, until 12-04-2024
listed in the 2024 annual accounts, filed on 07-04-2025
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- “Chaque gérant - aussi lorsqu'il y en a plusieurs - représente la société vis-à-vis de tiers, ainsi qu'en justice…”deed of 15-12-2017
Mandates through the years
1 name, the dashed line is todayDirector (not named in the articles)
BoardEarliermandate already running before its first mention
Mandates as a list
-
- Manager (not named in the articles), appointed by deed of 15-12-2017, until 12-04-2024
- Director (not named in the articles), since before 12-04-2024
Control
Shareholder
This company
Clinistique
Equity -€23,268
Profit €25,147 in 2024
Capital
- Contribution
- €18,600
- Shares
- 100
- Contribution per share
- €186
- Equity per share
- -€233 in 2024
- Source
- deed of 12-04-2024
Articles of association
deed of 12-04-2024 (in French)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
- Cession d'actions, tenus de solliciter agrément selon mêmes formalités s'ils ne deviennent pas de plein droit actionnaires
- Share issue ruleThe articles set how and by whom new shares are issued.
- Apport en numéraire avec émission de nouvelles actions - Droit de préférence, organe d'administration qui procède à l'émission
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Fourth Friday of March at 14:00
Shareholders
Stated in the deed
deed of 12-04-2024 ↗
- all shares
At incorporation
deed of 15-12-2017 ↗
- 100 shares (100%)
Capital transactions
Capital over time
- 12-04-2024 Converted to unavailable equity · €18,600
- 15-12-2017 Incorporation · €18,600 · 100 shares